Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2022-07-20 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
220720 - Acquisition and disposal of own shares_ENG (final).pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Acquisition and disposal of own shares" and provides detailed tables showing the number of shares repurchased (acquired) and disposed of by UCB SA/NV between July 15 and July 19, 2022, referencing the Share Repurchase Program 2022 and Long Term Incentive Plans. This activity directly relates to the company buying back or selling its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a direct disclosure of these transactions, not merely an announcement that a report is forthcoming (which would suggest RPA or RNS).
2022-07-20 English
220720 - Rachat et aliénation d'actions propres_FR (final).pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Rachat et aliénation d'actions propres" (Share repurchase and disposal) and details transactions where UCB SA repurchased its own shares on Euronext Brussels between July 15 and July 19, 2022, and also disposed of shares following employee option exercises. This directly corresponds to the definition of a report concerning the company buying back or selling its own shares. This matches the definition for Transaction in Own Shares (Code: POS). The document length is short (3738 chars) and it is a direct announcement of transactions, not an announcement *about* a report, so RPA/RNS is not the primary classification.
2022-07-20 French
220720 - Verwerving en vervreemding van eigen aandelen_NL (final).pdf
Transaction in Own Shares Classification · 1% confidence The document explicitly details the 'Verwerving en vervreemding van eigen aandelen' (Acquisition and disposal of own shares). It provides specific transaction dates (July 15 to July 19, 2022), quantities of shares bought back, average prices paid, and details on the disposal of shares related to Long-Term Incentive (LTI) plans. This content directly corresponds to the definition of a company reporting transactions involving its own shares, which maps to the 'Transaction in Own Shares' category (POS). The document is a formal announcement ('Gereglementeerde informatie') detailing these buybacks and disposals.
2022-07-20 Dutch
220715 - Acquisition and disposal of own shares_ENG (final).pdf
Transaction in Own Shares Classification · 1% confidence The document explicitly details the 'Acquisition and disposal of own shares' by UCB SA/NV, providing specific transaction dates, volumes, and prices related to its Share Repurchase Program. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category.
2022-07-15 English
220715 - Rachat et aliénation d'actions propres_FR (final).pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Rachat et aliénation d'actions propres" (Repurchase and disposal of own shares) and details transactions where UCB SA bought back its own shares on Euronext Brussels between July 8 and July 14, 2022, and also disposed of shares related to employee stock options. This activity directly corresponds to the definition of a company reporting on buying back or selling its own shares. This matches the definition for 'Transaction in Own Shares' (Code: POS). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it an Earnings Release (ER) or an Interim Report (IR).
2022-07-15 French
220715 - Verwerving en vervreemding van eigen aandelen_NL (final).pdf
Transaction in Own Shares Classification · 1% confidence The document text is titled "Verwerving en vervreemding van eigen aandelen" (Acquisition and disposal of own shares) and details specific transactions where UCB NV bought back its own shares (Aandelen Inkoopprogramma 2022) and disposed of shares related to employee stock options, providing dates, quantities, and prices. This activity directly corresponds to the definition of a company reporting on transactions involving its own stock. This matches the definition for 'Transaction in Own Shares' (Code: POS). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K), as it focuses solely on share repurchase/issuance activity.
2022-07-15 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.